APA

van der Heijden T., Kritikou E., Venema W., van Duijn J., van Santbrink P. J., Slütter B., Foks A. C., Bot I. & Kuiper J. (20170808). NLRP3 Inflammasome Inhibition by MCC950 Reduces Atherosclerotic Lesion Development in Apolipoprotein E-Deficient Mice-Brief Report. : Arteriosclerosis, thrombosis, and vascular biology.

Chicago

van der Heijden Thomas, Kritikou Eva, Venema Wouter, van Duijn Janine, van Santbrink Peter J, Slütter Bram, Foks Amanda C, Bot Ilze and Kuiper Johan. 20170808. NLRP3 Inflammasome Inhibition by MCC950 Reduces Atherosclerotic Lesion Development in Apolipoprotein E-Deficient Mice-Brief Report. : Arteriosclerosis, thrombosis, and vascular biology.

Harvard

van der Heijden T., Kritikou E., Venema W., van Duijn J., van Santbrink P. J., Slütter B., Foks A. C., Bot I. and Kuiper J. (20170808). NLRP3 Inflammasome Inhibition by MCC950 Reduces Atherosclerotic Lesion Development in Apolipoprotein E-Deficient Mice-Brief Report. : Arteriosclerosis, thrombosis, and vascular biology.

MLA

van der Heijden Thomas, Kritikou Eva, Venema Wouter, van Duijn Janine, van Santbrink Peter J, Slütter Bram, Foks Amanda C, Bot Ilze and Kuiper Johan. NLRP3 Inflammasome Inhibition by MCC950 Reduces Atherosclerotic Lesion Development in Apolipoprotein E-Deficient Mice-Brief Report. : Arteriosclerosis, thrombosis, and vascular biology. 20170808.